Skip to Main Content

RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept
RTI International
  • About
    • Office Locations
    • Executive Leadership
    • Corporate Governance
    • Partner with Us
      • U.S. Government
      • Clients and Funding Agencies
      • Industry and Commercial Clients
      • Foundations and Associations
      • Bilateral Agencies and Multilateral Banks
      • Universities and Academic Research Institutions
      • Suppliers and Small Businesses
    • Commitment to Quality
      • RTI's Client Listening Program
    • Ethics and Human Research Protection
    • Living Our Mission
    • Veteran Opportunities at RTI

    About

  • Practice Areas
    • Health
      • Public Health and Well-Being
      • Health Care Transformation
      • Behavioral Health
      • Health Behavior Change
      • Precision Medicine
      • RTI Health Solutions (RTI-HS)
      • RTI Center for Community Health Evaluation and Economics Research
      • Health Equity
      • RTI Health Advance
    • Transformative Research Unit for Equity​
      • Equity Capacity Building Hub
      • Social and Economic Justice Research Collaborative
      • Narrative Research and Community Engagement Lab
    • Education and Workforce Development
      • Early Childhood
      • K-12 Education
      • Postsecondary Education
      • Career and Adult Education and Workforce Development
      • Education Policy, Systems, and Governance
      • Education Research Methodologies
      • Education Technologies
    • International Development
      • Energy for Development
      • Environment
      • Global Food Security, Agriculture, and Nutrition
      • Global Health
      • International Education
      • Monitoring, Evaluation, Research, Learning, and Adapting (MERLA)
      • Youth and Economic Opportunity
      • Building Resilience Against COVID-19 in Developing Countries
      • Water, Sanitation, and Hygiene (WASH)
      • RTI Center for Governance
    • Climate Change
      • Clean Energy Technology and Renewables
      • Climate Finance
      • Climate Justice and Equity
      • Climate Planning, Preparedness and Resilience
      • Climate Policy
      • Climate Vulnerability, Adaptation, and Mitigation
      • Economic Impacts of Climate Change
    • Water
      • Food-Energy-Water Nexus
      • Water Quality
      • WASH (Water, Sanitation, Hygiene)
      • Water Resources Management
    • Energy Research
      • Carbon Capture and Utilization
      • Biomass Conversion
      • Natural Gas
      • Energy Efficiency
      • Industrial Water
      • Syngas Processing
    • Environmental Sciences
      • Air Quality
      • RTI Center for Water Resources
      • Urban Sustainability
      • Toxics
      • Building Resiliency in the FEW Nexus
      • Climate Change Sciences and Analysis
      • Environmental Policy
      • Environmental Justice
      • Sustainable Materials & Waste Management Solutions
    • Justice Research and Policy
      • RTI Center for Community Safety and Crime Prevention
      • RTI Center for Policing Research and Investigative Science
      • Child Well-Being and Family Strengthening
      • RTI Center for Forensic Sciences
    • Food Security and Agriculture
      • Market Systems Strengthening
      • Food Safety
      • Food and Nutrition
      • Global Food Security, Agriculture, and Nutrition
      • Climate-Smart Agriculture
      • Agricultural Innovation
      • Obesity Prevention
    • Innovation Ecosystems
      • Innovation Advising
      • Innovation for Economic Growth
      • Innovation for Emerging and Developing Economies
      • Innovation for Organizations
      • Research, Technology, and Innovation Policy
      • Technology Acceleration
    • Military Support
      • Military Behavioral Health
      • Military Health and Human Performance
      • Military Sexual Assault, Harassment, and Domestic Violence Prevention
      • Wearable Sensor Technologies
      • Military Health System Transformation

    Practice Areas

  • Services + Capabilities
    • Surveys and Data Collection
      • Survey Design
      • Instrument Development
      • Survey Methodologies
      • Data Collection
      • Establishment Surveys
      • Health Registries
      • Data Analysis and Reporting
      • Research Operations Center
    • Statistics and Data Science
      • Survey Statistics
      • Environmental Statistics
      • Coordinating Centers for Multisite Studies
      • Analysis and Design of Complex Data
      • Biostatistics
      • RTI Center for Data Science
    • Evaluation, Assessment and Analysis
      • Evaluation Design and Execution
      • Advanced Qualitative, Quantitative, and Mixed Methods
      • Evaluation, Monitoring, and Assessment
      • Economic Analysis
      • Evaluating Communication Interventions and Campaigns
      • Evidence Synthesis for Policy and Practice
      • Risk Assessment and Prediction
    • Program Design and Implementation
      • Systems Strengthening and Scaling
      • Capacity Assessment and Building
      • Policy Reform Support
      • Curriculum and Teacher Professional Development
      • Interventions and Prevention Programs
      • Implementation Science
    • Digital Solutions for Social Impact
      • Human-Centered Design of Digital Solutions
      • Digital Product Development
      • Digital Communication Campaigns
      • Digital Data Analytics
    • Research Technologies
      • Survey Technologies
      • Data Management and Decision Support Systems
      • Geospatial Science, Technology, and Visualization
      • ICT for Limited-Resource Settings
      • Mobile Applications
      • Web Applications
      • Bioinformatics
      • Interactive Computing
    • Drug Discovery and Development
      • Medicinal Chemistry
      • Molecular Design and Cheminformatics
      • Behavioral Pharmacology
      • Drug Metabolism and Pharmacokinetics (DMPK)
      • In Vitro Pharmacology, Bioassay Development, and High-Throughput Screening (HTS)
      • Isotope Labeling
      • Regulatory Consulting and Support for Medical Products
    • Analytical Laboratory Sciences
      • Bioanalytical and Toxicology Research
      • Forensic Sciences
      • Physicochemical Characterizations
      • Metabolomics
      • Proficiency Testing and Reference Materials
      • Microbiology
      • Analytical Chemistry and Pharmaceutics
    • Engineering & Technology R&D
      • Biomedical Technologies
      • Decarbonization Sciences
      • Environmental Exposure & Protection
      • Materials & Environment
      • Sustainable Energy Solutions

    Services + Capabilities

  • Centers
    • RTI Center for Advanced Methods Development
    • RTI Center for Communication Science
      • Communication Research
      • Communication Design
      • Communication Delivery
    • RTI Center for Data Science
    • RTI Center for Education Services
      • Teaching and Learning
      • Education Leadership
      • Peer Learning Networks
      • Strategic Consulting
    • RTI Center for Forensic Sciences
    • RTI Center for Global Noncommunicable Diseases
      • Program Financing & Economics for NCDs
      • Health Systems Strengthening for NCDs
      • Communication Science and Behavior Change for NCDs
      • Implementation Science for NCDs
    • RTI GenOmics, Bioinformatics, and Translational Research Center
      • Disability Studies
      • Ethics
      • Newborn Screening
    • RTI Center for Water Resources
      • Water Resources Sectors
      • Water Resources Services
      • Water Resources Tools
    • RTI Center for Governance
    • RTI Global Gender Center
    • North Carolina Center for Optimizing Military Performance
    • NCCU-RTI Center for Applied Research in Environmental Sciences
    • RTI Center for Climate Solutions

    Centers

  • Impact
    • Newsroom
    • Insights Blog
    • Events
    • Publications
    • RTI Press
      • About the RTI Press
      • Instructions for Authors
      • RTI Press Collections
    • Projects
    • Global Reach
      • Asia
      • Eastern Europe and Central Asia
      • RTI International India
      • Africa
      • Middle East and North Africa (MENA)
      • Latin America and the Caribbean (LAC)

    Impact

  • Experts
    • Our Experts
    • In-Depth With Our Experts
    • Related News
    • Experts In the Media
    • RTI Fellow Program

    Experts

  • Emerging Issues
    • COVID-19 Research
    • Artificial Intelligence
    • Global Health Security
    • Cannabis Research
    • Opioid Research
      • Interventions for Opioid Use Disorders
      • Preventing Opioid Misuse and Overdose
      • Treating Opioid Use Disorders
    • Policing Research and Investigative Science
    • Drone Research and Application
    • E-cigarette Research
    • Zika Virus Research
    • Integrated Governance

    Emerging Issues

  • COVID-19 Research + Response
  • Global Reach
  • Insights Blog
  • Newsroom
  • RTI Press
  • Publications
  • Partner With Us
  • Careers
  • Facebook IconTwitter IconInstagram IconYouTube IconLinkedin Icon
  • Home
  • Impact
  • RTI Press
  • Young breast cancer survivors

Young breast cancer survivors

Employment experience and financial well-being

By Florence K L Tangka, Sujha Subramanian, Madeleine Jones, Sonja Hoover, Patrick Van Edwards, Tim Flanigan, Jenya Kaganova, Kevin Smith, Nikki A Hawkins, Juan Rodriguez, Arin Ahlum Hanson, Janine Guglielmino, Michelle Esser, Gery P Guy Jr., Cheryll C Thomas, Temeika Fairley.

July 2020 Open Access Peer Reviewed

DOI: 10.3768/rtipress.2020.rr.0041.2007

Check for Updates Download PDF
Tangka, F. K. L., Subramanian, S., Jones, M., Hoover, S., Edwards, P. V., Hoover, S., Flanigan, T., Kaganova, J., Smith, K., Hawkins, N. A., Rodriguez, J., Hanson, A. A., Guglielmino, J., Esser, M., Guy Jr., G. P., Thomas, C. C., & Fairley, T. (2020). Young breast cancer survivors: Employment experience and financial well-being. RTI Press. RTI Press Research Report No. RR-0041-2007 https://doi.org/10.3768/rtipress.2020.rr.0041.2007
Copy citation
Share
  • Share on Facebook
  • Share on Twitter
  • Share on Linkedin
  • Email
Key Points
  • We administered a web-based survey to a national convenience sample of 416 women who were 18–49 years of age at the time of their breast cancer diagnosis to determine the economic burden of breast cancer for US women under 50.
  • Survivors 18–39 years of age at first diagnosis quit their jobs more often (14.6%) than survivors aged 40–49 (4.4%; P < 0.01) and faced more job performance issues (55.7% and 42.8%, respectively; P = 0.02).
  • For all respondents, financial decline was more likely if the survivor had at least one comorbid condition (odds ratios: 2.36–3.21) or was diagnosed at Stage II–IV breast cancer (odds ratios: 2.04–3.51).

Abstract

The economic burden of breast cancer for women under 50 in the United States remains largely unexplored, in part because young women make up a small proportion of breast cancer cases overall. To address this knowledge gap, we conducted a web-based survey to compare data from breast cancer survivors 18–39 years of age at first diagnosis and 40–49 years of age at first diagnosis.We administered a survey to a national convenience sample of 416 women who were 18–49 years of age at the time of their breast cancer diagnosis. We analyzed factors associated with financial decline using multivariate regression.Survivors 18–39 years of age at first diagnosis were more likely to report Stage II–IV breast cancer (P < 0.01). They also quit their jobs more often (14.6%) than older survivors (4.4%; P < 0.01) and faced more job performance issues (55.7% and 42.8%, respectively; P = 0.02). For respondents in both groups, financial decline was more likely if the survivor had at least one comorbid condition (odds ratios: 2.36–3.21) or was diagnosed at Stage II–IV breast cancer (odds ratios: 2.04–3.51).

Creative Commons © 2023 RTI International. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Contents

  • Introduction
  • Methods
  • Results
  • Discussion
  • Conclusion
  • Acknowledgments
  • References
  • Appendix

Young Breast Cancer Survivors: Employment Experience and Financial Well-Being

By Florence K. L.TangkaSujhaSubramanianMadeleineJonesPatrickEdwardsSonjaHooverTimFlaniganJenyaKaganovaKevinSmithNikki A.HawkinsJuanRodriguezArin AhlumHansonJanineGuglielminoMichelleEsserGery P.GuyCheryll C.ThomasTemeikaFairley

Introduction

In 2015, about 18 percent of new breast cancer cases (43,446/242,463) were diagnosed in women younger than 50 years; 4 percent (10,679) were in women 18–39 years of age, and 14 percent (32,767) were in women 40–49 years of age.1 Breast cancer may have different effects on women younger than 50 years compared with women 50 years or older in terms of survivorship, fertility, and familial obligations. Breast cancer screening using mammography is only recommended for older women (starting between 40 and 50 years depending on the specific recommendation or guideline).2 Women younger than 50 years have reported greater concerns about their treatment, their survival, and the effects of treatment on fertility and prospects for having children.3, 4

Breast cancer survivors (women who have received a breast cancer diagnosis) younger than 50 years may want to continue education or employment, and undergoing cancer treatments during this phase of life can put these opportunities on hold.5 To date, employment and financial burden research has primarily focused on breast cancer survivors in specific geographic areas of the United States. Approximately one-quarter of breast cancer survivors in one study experienced a financial decline, attributed at least in part to their breast cancer.6 This study further reported that many breast cancer survivors retained their jobs to maintain health insurance or found new employment to acquire health insurance benefits.6 In terms of continuing or returning to work after diagnosis or treatment, respondents were more willing to do so if they perceived their employers as accommodating, and less likely to do so if they perceived employer discrimination on account of their diagnosis.7

Although existing studies compare these challenges across age groups, limited information is available about the employment experiences of breast cancer survivors across the entire United States.6 To fill these gaps in knowledge, we developed a nationwide, web-based survey to collect information on the experiences of breast cancer survivors younger than 50 years at time of first diagnosis. The survey emphasized effects on employment and the financial burden of the disease. The study compared breast cancer survivors first diagnosed at 18–39 years with breast cancer survivors first diagnosed at 40–49 years to explore whether the younger age group would report greater employment and financial burden. We included women up to the age of 50 at diagnosis for this survey, as there is no clear definition of “young” breast cancer survivors. Some studies include only those under 40 years of age at diagnosis; others consider patients under 45 years or even under 50 years of age at diagnosis to be in the young cohort.

Methods

We recruited a convenience sample of breast cancer survivors from two breast cancer interest groups: Living Beyond Breast Cancer and Young Survival Coalition. The interest groups posted announcements on their Facebook pages, invited participants via e-mails, and announced the survey in electronic newsletters. No incentive was provided.

Survey participation was based on interest-group affiliation rather than random sampling methods. Participants were included in the sample if they were female and had been diagnosed with breast cancer between the ages of 18 and 49. Women were ineligible if they had been diagnosed with breast cancer more than 10 years before completing the survey or if they lived in California, Florida, Georgia, or North Carolina and were diagnosed with breast cancer between January 1, 2013, and December 31, 2014. These women were excluded because they were targeted for participation in a similar survey using cohorts drawn from cancer registry databases in these four states.

The survey questionnaire was web-based. The questions were informed by past literature surveying cancer patients6, 8–10 and, whenever feasible, used question wording from prior surveys such as the National Health Interview Survey, the Medical Expenditure Panel Survey, and the Consumer Assessment of Health Plans. We developed the questions in both English and Spanish. To ensure appropriateness and clarity of the questions in the online survey for low-income and low-education respondents, we conducted cognitive testing of the survey in English (nine breast cancer survivors) and in Spanish (eight breast cancer survivors) in Raleigh/Durham, NC; Washington, DC; and Houston, TX.

Overall, the questionnaire contained 66 questions on employment status, insurance status, financial burden of treatment, quality of care, quality of life, cancer history, and demographics, such as the age at first diagnosis, race/ethnicity, marital status, and education. The quality-of-life items were taken directly from the Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index but all other items were adapted from validated tools and refined for our specific sample population. Validated tools that served as sources included the Medicaid Consumer Assessment of Healthcare Providers and Systems and the National Health Interview Survey. We honed each survey item for low-income and low-literacy populations and performed extensive cognitive testing on the draft survey instrument to identify problems with response options before the survey was fielded.

We provided respondents with a list of comorbid conditions, including cardiovascular conditions, circulatory problems, vision issues, depression, migraines, back problems, arthritis, and thyroid problems, and instructed them to select all that applied. A write-in “other” option was also supplied. For the analyses in this study, we calculated a summary comorbidity score (no conditions, one condition, or two or more conditions). Clinical variables examined included stage at diagnosis and type of treatment received; treatments could include surgery, chemotherapy, radiation therapy, hormone therapy, and immunotherapy. Respondents were also asked whether they were undergoing treatment at the time of survey administration.

The survey was conducted via the web nationally from October 2016 through June 2017 and took approximately 20 minutes to complete. The survey probed insurance coverage, type, and experiences, encompassing details on insurance status at the time the survey was conducted (12 months post-diagnosis), at diagnosis, and during the year-long period after diagnosis. Questions about employment status at the time of breast cancer diagnosis included the type of job, hours-per-week worked, and detailed measures of employment before and after cancer diagnosis. Questions also captured any issues maintaining and seeking new employment after breast cancer diagnosis, such as needing to change jobs within a company, moving to a new company for health insurance, staying in a job to keep health insurance, taking time off without pay, retiring early, or quitting a job. Respondents also were asked about the level of support they received from their employers during breast cancer treatment (e.g., whether their employers were aware of their breast cancer diagnosis). In addition, respondents were asked to report on any decline in their financial status caused by their breast cancer diagnosis. Financial decline was measured categorically: “not much,” “a little,” “somewhat,” “quite a bit,” or “very much.”

We used descriptive statistics to compare women first diagnosed between the ages of 18 and 39 with those first diagnosed between the ages of 40 and 49. We used logistic regression to examine factors related to perceived breast cancer–related financial decline. The outcome variable measured the financial impact of the respondent’s breast cancer diagnosis. Responses ranging from “somewhat” to “very much” were coded as 1, while “none,” “not much,” and “a little” were coded as 0. Control variables included age at diagnosis, race/ethnicity, marital status, education, employment status, comorbid conditions, stage of diagnosis, and whether the woman was currently receiving breast cancer treatment. We conducted descriptive and regression analyses using Stata.11 Statistical significance was defined as P  <  0.05.

Results

A total of 674 respondents provided electronic informed consent and began the surveys (see Figure A.1 in the Appendix). Of these, 258 respondents were excluded from further analysis: 160 completed only a small portion of the survey, 70 did not provide values for key variables, and 28 had been diagnosed with breast cancer more than 10 years before completing the survey. The final study population included 416 respondents.

The demographic characteristics of the two age groups were generally similar (Table 1). In both age groups, more than 80 percent of the survivors were non-Hispanic white, at least 75 percent had either a college or graduate degree, and at least 75 percent were married or had a partner. More than 50 percent of the survivors had two or more comorbid conditions at the time of the survey, and more than 25 percent had one comorbid condition.

Approximately two-thirds of the respondents were in treatment at the time of the survey (Table 1). Survivors 18–39 years of age were more likely to report Stage II, III, or IV breast cancer and to report receiving chemotherapy or immunotherapy. Although more than 90 percent of survivors in both age groups reported receipt of surgery, a higher proportion of survivors 40–49 years of age reported surgery (P  =  0.05).

Baseline demographic and clinical characteristics by age at diagnosis among survey respondents, 2016–2017
Age at diagnosis
18–39 years 40–49 years P
n = 251 n = 165
Race/ethnicity 0.911
   Non-Hispanic white    210 (83.7%)    141 (85.5%)
   Non-Hispanic black    13 (5.2%)    8 (4.9%)
   Hispanic    12 (4.8%)    5 (3.0%)
   Non-Hispanic Asian/Pacific Islander    6 (2.4%)    5 (3.0%)
   Non-Hispanic other    10 (4.0%)    6 (3.6%)
Education (at the time of survey response) 0.112
   Graduate degree    101 (40.4%)    66 (40.0%)
   College graduate    97 (38.8%)    58 (35.2%)
   Some college    47 (18.8%)    30 (18.2%)
   High school or less    5 (2.0%)    11 (6.7%)
Marital status (at the time of survey response) 0.468
   Single    47 (18.7%)    20 (12.1%)
   Married or with partner    193 (76.9%)    130 (78.1%)
   Divorced or separated    9 (3.6%)    14 (8.5%)
   Unknown    2 (0.8%)    1 (0.6%)
Comorbid conditions (at the time of survey response) 0.764
   None    51 (20.3%)    34 (20.6%)
   One condition    64 (25.5%)    47 (28.5%)
   Two or more conditions    136 (54.2%)    84 (50.9%)
Stage at diagnosis < 0.001
   Stage 0    12 (4.8%)    21 (13.0%)
   Stage I    54 (21.7%)    55 (34.0%)
   Stage II    100 (40.2%)    54 (33.3%)
   Stage III    63 (25.1%)    27 (16.5%)
   Stage IV    20 (8.0%)    5 (3.1%)
Treatments received
   Surgery    233 (92.8%)    162 (98.2%)    0.046
   Radiation therapy    150 (59.8%)    89 (53.9%)    0.240
   Chemotherapy    211 (84.1%)    101 (61.2%)    < 0.001
   Hormone therapy    180 (71.7%)    115 (69.7%)    0.658
   Immunotherapy    84 (33.5%)    29 (17.6%)    < 0.001
Receiving treatment (at the time of survey response) 164 (65.3%)        98 (59.4%) 0.219
Source: Data were collected from October 2016 through June 2017 under Office of Management and Budget (OMB) approval No. 0920–1123 received for the Breast Cancer in Young Women Survey.

Respondents 18–39 years of age reported a decline in employment; 88.5 percent had been employed at the time of diagnosis, but 74.0 percent were employed at the time of the survey (Figure 1). Women 40–49 years of age experienced a decline in employment from 83.6 percent at the time of diagnosis to 73.3 percent at the time of the survey. These declines were statistically significant for both age groups.

Employment status by age at diagnosis among survey respondents, 2016–2017

Note: Difference in employment status at diagnosis and time of survey are statistically significant for both groups (P = 0.001).

Source: Data were collected October 2016 through June 2017 under Office of Management and Budget approval No. 0920-1123 received for the Breast Cancer in Young Women.

In both age groups, about 10 percent of survivors reported that their employers had not been supportive at the time of first diagnosis (Table 2). Among survivors who had been working at time of first diagnosis, the proportion of survivors 18–39 years of age who had quit their job by the time of the survey (14.6 percent) was about three times larger than the proportion of those 40–49 years of age who had done so (4.4 percent) (P  <  .01). Job performance issues were reported by 55.7 percent of survivors 18–39 years of age and 42.8 percent of survivors 40–49 years of age (P  =  .02). Overall, about 75 percent of survivors reported that their employment was quite important or very important to their financial standing. Overall, more than half of the breast cancer survivors (54.2 percent) reported a financial decline (see Figure A.2 in the Appendix for descriptive statistics on financial decline by age at diagnosis and treatment status).

Employment impacts by age at diagnosis among survey respondents, 2016–2017
Age at diagnosis
18–39 years 40–49 years P
Level of employer support (among those working at the time of diagnosis) 0.452
   Supportive    184 (84.0%)    108 (78.8%)
   Neutral    12 (5.5%)    12 (8.8%)
   Not supportive    21 (9.6%)    14 (10.2%)
   Unaware    2 (0.9%)    3 (2.2%)
Types of employment impacts (among those working at the time of diagnosis)
   Had job performance issues    122 (55.7%)    59 (42.8%)    0.017
   Took unpaid time off    107 (48.9%)    55 (40.2%)    0.108
   Kept job for health insurance coverage    83 (38.1%)    51 (37.2%)    0.873
   Avoided changing jobs to keep health insurance    75 (34.3%)    33 (23.9%)    0.038
   Quit job    32 (14.6%)    6 (4.4%)    0.002
   Changed jobs within company    20 (9.2%)    5 (3.6%)    0.046
   Increased work hours to cover medical expenses    11 (5.0%)    12 (8.7%)    0.169
   Lost job    10 (4.6%)    5 (3.7%)    0.663
   Retired early    6 (2.8%)    7 (5.1%)    0.256
   Got a new job for health insurance coverage    5 (2.3%)    4 (2.9%)    0.718
Financial importance of work 0.153
   Not important    12 (4.8%)    12 (4.5%)
   A little important    13 (5.2%)    14 (8.5%)
   Somewhat important    34 (13.6%)    13 (7.9%)
   Quite important    41 (16.4%)    27 (16.4%)
   Very important    150 (60.0%)    97 (58.8%)
Source: Data were collected from October 2016 through June 2017 under Office of Management and Budget (OMB) approval No. 0920–1123 received for the Breast Cancer in Young Women Survey.

After adjusting for multiple factors (see Table 3), we found financial decline was not associated with age at diagnosis, race/ethnicity, education, or receipt of treatment at the time the survey was completed. Financial decline was significantly more likely if the survivor had reported one (odds ratio [OR], 2.36; 95 percent confidence interval [CI], 1.27–4.39) or two or more (OR, 3.21; 95 percent CI, 1.83–5.63) comorbid conditions, compared with no comorbid conditions. Financial decline was also significantly more likely for those whose first diagnosis was at Stage II (OR, 2.04; 95 percent CI, 1.24–3.33) or at Stage III or IV (OR, 3.51; 95 percent CI, 2.01–6.13), compared with Stage 0 or I. Financial decline was significantly less likely among survivors who were married or who had a partner (OR, 0.51; 95 percent CI, 0.30–0.88) and among survivors who had a job (OR, 0.59; 95 percent CI, 0.3–0.98).

Multivariate regression analysis of factors potentially related to financial decline among young women with breast cancer, 2016–2017
Covariate OR 95% CI P
Age at diagnosis
   40–49 years (reference)    1.00
   18–39 years    1.13    0.73 to 1.75    0.585
Race/ethnicity
   Non-white (reference)    1.00
   Non-Hispanic white    0.92    0.30 to 0.88    0.509
Marital status
   Unmarried (reference)    1.00
   Married or with partner    0.51    0.30 to 0.88    0.016
Education
   Less than college (reference)    1.00
   College    0.95    0.53 to 1.69    0.862
   Postgraduate    0.75    0.42 to 1.34    0.320
Employment status (at the time of survey response)
   Unemployed (reference)    1.00
   Employed    0.59    0.3 to 0.98    0.041
Comorbid conditions (at the time of survey response)
   0 (reference)    1.00
   1    2.36    1.27 to 4.39    0.007
   2 or more    3.21    1.83 to 5.63    < 0.000
Stage
   0, I (reference)    1.00
   II    2.04    1.24 to 3.33    0.005
   III, IV    3.51    2.01 to 6.13    < 0.001
Receiving treatment (at the time of survey response) 1.30 0.84 to 2.01 0.234
Notes: OR = odds ratio; CI = confidence interval.
Source: Data were collected from October 2016 through June 2017 under Office of Management and Budget (OMB) approval No. 0920–1123 received for the Breast Cancer in Young Women Survey.

Discussion

Compared with breast cancer survivors 40–49 years of age, survivors 18–39 years of age were more likely to report Stage II, III, or IV breast cancer at time of first diagnosis, that they had quit their job, and that they had job performance issues. Financial decline was not associated with age group but was associated with late-stage disease and comorbidity.

Few prior studies have specifically addressed the financial burden of breast cancer among younger women.12–15 The current study findings in younger breast cancer survivors are consistent with prior studies on the economic impact on breast cancer survivors of all age groups (such as job discontinuation and decreased working hours).16–22 Several studies of breast cancer survivors of all ages have documented a substantial employment disruption over the course of the diagnosis and treatment process.16, 21 Being employed improves the quality of life of cancer patients in numerous ways; for example, it is a source of income, health insurance, social interactions, and distraction. Protracted breast cancer treatment and recovery can disrupt patient employment and affect other aspects of patient quality of life.16, 23–25

Although all young women diagnosed with breast cancer experienced a decline in employment, the current study also found a somewhat larger decline in employment after a breast cancer diagnosis for women 18–39 years of age (14.5 percent) than those 40–49 years of age (10.3 percent). Furthermore, compared with women 40–49 years of age, more women 18–39 years of age struggled with job performance, avoided changing jobs to keep their health insurance, changed jobs within their company, or quit working altogether. Further research is needed to assess whether younger women, who may not be as established in their careers and therefore have less seniority than older women, have limited ability to negotiate a more-flexible work schedule with employers. This study did not directly evaluate the role of sick leave in employment. Other studies have suggested that having sick leave available is associated with a greater likelihood of reemployment in breast cancer survivors.7, 26

The regression analysis found that financial decline was associated with late-stage disease and comorbidity but found no statistically significant difference by age group. Financial decline could result from breast cancer–related unemployment or reduced working hours and associated loss of income and employment-based insurance.23 Our findings suggest that breast cancer survivors who were married or had a partner and were employed were less likely to experience financial hardship, whereas survivors who had comorbidities and were diagnosed with late-stage disease were more likely to experience financial decline. Given these findings, decision makers may want to consider offering tailored chronic disease management services when seeking to reduce the financial burden for breast cancer survivors. These services could include patient navigation support to help cope with comorbidities and counseling to help with financial planning. Furthermore, research is also needed on optimal approaches to identify breast cancers at an earlier stage in younger women, potentially including education on breast health awareness and ways to monitor changes in their breast, as this may also reduce the financial hardship faced by these survivors. Providing education to both young women and their health care providers may lead to better understanding of breast cancer symptoms and may reduce the delays in diagnosis often experienced by these young women.

A key strength of this study is its focus on breast cancer survivors younger than 49 years. A potential limitation is the small sample size of the study, which may have limited our power in assessing differences among breast cancer survivors by age group. Another limitation is potential selection bias, as respondents volunteered to take this web-based survey. Given the accrual via web-based sources (Facebook, email, etc.), there is a strong bias toward women with access to these resources, as reflected in the relatively high education level of our sample. This may have implications for the generalizability of our results to the broader cohort of young women in the United States diagnosed with breast cancer. In general, the convenience sampling approach limited our ability to make statistical inferences. It is possible that only women who experienced barriers chose to complete the survey, but we were unable to verify the direction of any potential bias. We were also unable to provide the response rate for our survey, as we did not target a specific cohort of women diagnosed with breast cancer before the age of 50. All information on clinical diagnosis related to breast cancer was self-reported and thus also could be subject to recall bias.

This study adds to the limited literature on the impacts of breast cancer diagnosis on the employment and financial well-being of young women. Most breast cancers are diagnosed in women older than 40 years, but the financial burden of breast cancer related to employment appears to be high among young survivors 18–39 years of age. Increased understanding of the negative impacts on employment and financial resources of young breast cancer patients could inform interventions, such as financial counseling, to help survivors better cope and thrive after their breast cancer diagnosis. Because the results of this web-based survey may have been biased by the self-selection of participants, additional studies with randomly selected participants may be useful in confirming the conclusions on the financial impact of breast cancer diagnosis among young women.

Conclusion

Compared with breast cancer survivors 40–49 years of age, survivors 18–39 years of age were more likely to report late-stage breast cancer at the time of first diagnosis. Financial decline was strongly associated with late-stage disease. They also experienced more negative employment consequences: they were more likely to quit their job, and they had higher levels of job performance issues. The findings from this study can be used to inform discussions by policy makers on ways to reduce the financial impact of breast cancer diagnosis and treatment on young women. Research is needed on support strategies such as more-comprehensive insurance coverage with limits on out-of-pocket payments and other policies that enable young breast cancer patients to maintain job security while they undergo and recover from treatment.

Acknowledgments

The findings in this manuscript are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention (CDC).

Funding support for RTI staff was provided by the CDC (Contract N0. 200-2008-27958 Task 48, to RTI International).

Data were collected October 2016 through June 2017 under Office of Management and Budget (OMB) approval No. 0920-1123 received for the Breast Cancer in Young Women Survey.

The authors declare no potential conflicts of interest.

RTI Press Associate Editor: Denise Tyler

References

1US Cancer Statistics Working Group. US Cancer Statistics Data Visualizations Tool, based on November 2017 submission data (1999–2015). Atlanta (GA): Centers for Disease Control and Prevention and National Cancer Institute; 2018 [updated 2018 Jun; cited 2018 Aug 29]. Available from: https://www.cdc.gov/cancer/uscs/dataviz/index.htm
2Kerlikowske K. Progress toward consensus on breast cancer screening guidelines and reducing screening harms. JAMA Intern Med 2015;175(12):1970–1. 10.1001/jamainternmed.2015.646626502319
3Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 2004;22(20):4174–83. 10.1200/JCO.2004.01.15915483028
4Park EM, Gelber S, Rosenberg SM, Seah DS, Schapira L, Come SE et al. Anxiety and depression in young women with metastatic breast cancer: a cross-sectional study. Psychosomatics 2018;59(3):251–8. 10.1016/j.psym.2018.01.00729525523
5Partridge AH, Ruddy KJ, Kennedy J, Winer EP. Model program to improve care for a unique cancer population: young women with breast cancer. J Oncol Pract 2012;8(5):e105–10. 10.1200/JOP.2011.00050123277772
6Jagsi R, Pottow JA, Griffith KA, Bradley C, Hamilton AS, Graff J et al. Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol 2014;32(12):1269–76. 10.1200/JCO.2013.53.095624663041
7Bouknight RR, Bradley CJ, Luo Z. Correlates of return to work for breast cancer survivors. J Clin Oncol 2006;24(3):345–53. 10.1200/JCO.2004.00.492916421415
8Arora NK, Reeve BB, Hays RD, Clauser SB, Oakley-Girvan I. Assessment of quality of cancer-related follow-up care from the cancer survivor’s perspective. J Clin Oncol 2011;29(10):1280–9. 10.1200/JCO.2010.32.155421357781
9Malin JL, Diamant AL, Leake B, Liu Y, Thind A, Kahn KL et al. Quality of care for breast cancer for uninsured women in California under the breast and cervical cancer prevention treatment act. J Clin Oncol 2010;28(21):3479–84. 10.1200/JCO.2009.27.749120530279
10Smith T, Stein KD, Mehta CC, Kaw C, Kepner JL, Buskirk T et al. The rationale, design, and implementation of the American Cancer Society’s studies of cancer survivors. Cancer 2007;109(1):1–12. 10.1002/cncr.2238717146781
11StataCorp. Stata: Release 15. Statistical software. College Station (TX): StataCorp LLC; 2017.
12Allaire BT, Ekwueme DU, Guy GP Jr, Li C, Tangka FK, Trivers KF et al. Medical care costs of breast cancer in privately insured women aged 18–44 years. Am J Prev Med 2016;50(2):270–7. 10.1016/j.amepre.2015.08.03526775906
13Allaire BT, Ekwueme DU, Poehler D, Thomas CC, Guy GP Jr, Subramanian S et al. Breast cancer treatment costs in younger, privately insured women. Breast Cancer Res Treat 2017;164(2):429–36. 10.1007/s10549-017-4249-x28432514
14Ekwueme DU, Allaire BT, Guy GP Jr, Arnold S, Trogdon JG. Treatment costs of breast cancer among younger women aged 19–44 years enrolled in Medicaid. Am J Prev Med 2016;50(2):278–85. 10.1016/j.amepre.2015.10.01726775907
15Trogdon JG, Ekwueme DU, Poehler D, Thomas CC, Reeder-Hayes K, Allaire BT. Medical costs of treating breast cancer among younger Medicaid beneficiaries by stage at diagnosis. Breast Cancer Res Treat 2017;166(1):207–15. 10.1007/s10549-017-4386-228702893
16Jagsi R, Abrahamse PH, Lee KL, Wallner LP, Janz NK, Hamilton AS et al. Treatment decisions and employment of breast cancer patients: results of a population-based survey. Cancer 2017;123(24):4791–9. 10.1002/cncr.3095928990155
17Glare PA, Nikolova T, Alickaj A, Patil S, Blinder V. Work experiences of patients receiving palliative care at a comprehensive cancer center: exploratory analysis. J Palliat Med 2017;20(7):770–3. 10.1089/jpm.2016.047828562160
18Blinder V, Eberle C, Patil S, Gany FM, Bradley CJ. Women with breast cancer who work for accommodating employers more likely to retain jobs after treatment. Health Aff (Millwood) 2017;36(2):274–81. 10.1377/hlthaff.2016.119628167716
19Neumark D, Bradley CJ, Henry M, Dahman B. Work continuation while treated for breast cancer: the role of workplace accommodations. Ind Labor Relat Rev 2015;68(4):916–54. 10.1177/001979391558697426778848
20Blinder V, Patil S, Eberle C, Griggs J, Maly RC. Early predictors of not returning to work in low-income breast cancer survivors: a 5-year longitudinal study. Breast Cancer Res Treat 2013;140(2):407–16. 10.1007/s10549-013-2625-823884596
21Høyer M, Nordin K, Ahlgren J, Bergkvist L, Lambe M, Johansson B et al. Change in working time in a population-based cohort of patients with breast cancer. J Clin Oncol 2012;30(23):2853–60. 10.1200/JCO.2011.41.437522778312
22Hassett MJ, O’Malley AJ, Keating NL. Factors influencing changes in employment among women with newly diagnosed breast cancer. Cancer 2009;115(12):2775–82. 10.1002/cncr.2430119365847
23Saito N, Takahashi M, Sairenchi T, Muto T. The impact of breast cancer on employment among Japanese women. J Occup Health 2014;56(1):49–55. 10.1539/joh.13-0140-OA24430841
24Brown DS, Trogdon JG, Ekwueme DU, Chamiec-Case L, Guy GP Jr, Tangka FK et al. Health state utility impact of breast cancer in U.S. women aged 18–44 years. Am J Prev Med 2016;50(2):255–61. 10.1016/j.amepre.2015.07.02026775904
25Trogdon JG, Ekwueme DU, Chamiec-Case L, Guy GP Jr. Breast cancer in young women: health state utility impacts by race/ethnicity. Am J Prev Med 2016;50(2):262–9. 10.1016/j.amepre.2015.09.02626775905
26Barmby TA, Ercolani MG, Treble JG. Sickness absence: an international comparison. Econ J (Lond) 2002;112(480):F315–31. 10.1111/1468-0297.00046

Appendix

Final study sample selected for analysis, Breast Cancer in Young Women Survey, 2016–2017

Source: Data were collected from October 2016 through June 2017 under Office of Management and Budget (OMB) approval No. 0920–1123 received for the Breast Cancer in Young Women Survey.

Respondents who reported financial decline because of breast cancer by age at diagnosis and treatment status, 2016–2017

Notes: Overall, 54.2 percent of respondents reported financial decline. This metric includes those who reported “some,” “quite a bit,” and “very much” financial decline because of breast cancer. Those who reported “none,” “not much,” or “little” were coded as zero. None of the differences are statistically significant at the 5 percent level.

Source: Data were collected from October 2016 through June 2017 under Office of Management and Budget (OMB) approval No. 0920–1123 received for the Breast Cancer in Young Women Survey.

Click cover to download publication

Keep Exploring

  • icon-externallink-blue Created with Sketch.

    HTML version [Scholastica]

Contact

To contact an author or seek permission to use copyrighted content, contact our editorial team

  • +1 919 541 6490
  • rtipress@rti.org

Meet the Experts

View All Experts
Kevin Smith

Kevin Smith

Sujha Subramanian

Related Publications

View All Press
OCCASIONAL PAPER

Bringing an equity-centered framework to research

OCCASIONAL PAPER

The Preschool Entitlement

OCCASIONAL PAPER

Culturally informed community engagement

RESEARCH REPORT

Substance misuse prevention program attendance

RESEARCH BRIEF

COVID-19’s impact on clinical research

OCCASIONAL PAPER

Differentiated instruction in multigrade preprimary classrooms in Kenya

OCCASIONAL PAPER

Social determinants of health

OCCASIONAL PAPER

Challenges facing CAHPS surveys and opportunities for modernization

Recent Publications

View All Press
OCCASIONAL PAPER

Bringing an equity-centered framework to research

OCCASIONAL PAPER

The Preschool Entitlement

OCCASIONAL PAPER

Culturally informed community engagement

RESEARCH REPORT

Substance misuse prevention program attendance

RTI Logo
Partner With Us
  • US Government
  • Commercial
  • Foundations & Associations
  • Multilateral Donors
  • Universities
  • Suppliers
Site
  • Privacy Policy
  • Security Policy
  • Site Map
  • Terms of Use
  • Accessibility
  • Contact Us
Contact Us
Facebook Icon Twitter Icon Instagram Icon YouTube Icon Linkedin Icon
delivering the promise of science
for global good
RTI Health Solutions RTI Innovation Advisors RTI Health Advance

© 2023 RTI International. RTI International is a trade name of Research Triangle Institute. RTI and the RTI logo are U.S. registered trademarks of Research Triangle Institute.